Body

Anti-tobacco policies responsible for Brazil's big success in reducing smoking rates

Smoking rates in Brazil have dropped by half over the past two decades thanks to strict tobacco control policies, according to a study by US and Brazilian researchers published in this week's PLOS Medicine.

China health system reform needs more accountability

In this week's PLOS Medicine, David Hipgrave from the University of Melbourne, Australia and colleagues discuss health system reform in China and argue that parallel reforms in governance, financing, and accountability are also needed to ensure health equity.

Source: Public Library of Science

NIH study finds leisure-time physical activity extends life expectancy as much as 4.5 years

Leisure-time physical activity is associated with longer life expectancy, even at relatively low levels of activity and regardless of body weight, according to a study by a team of researchers led by the National Cancer Institute (NCI), part of the National Institutes of Health. The study, which found that people who engaged in leisure-time physical activity had life expectancy gains of as much as 4.5 years, appeared Nov. 6, 2012, in PLOS Medicine.

Discovery may help nerve regeneration in spinal injury

Scientists at the Universities of Liverpool and Glasgow have uncovered a possible new method of enhancing nerve repair in the treatment of spinal cord injuries.

It is known that scar tissue, which forms following spinal cord injury, creates an impenetrable barrier to nerve regeneration, leading to the irreversible paralysis associated with spinal injuries. Scientists at Liverpool and Glasgow have discovered that long-chain sugars, called heparan sulfates, play a significant role in the process of scar formation in cell models in the laboratory.

Physical activity and gain in life expectancy -- quantified

Boston, MA—We all know that exercise is good for you, but how good? While previous studies have shown the link between physical activity and a lower risk of premature mortality, the number of years of life expectancy gained among persons with different activity levels has been unclear—until now.

Breast cancer drug could halt other tumors

The drug, geldanamycin, is well known for attacking a protein associated with the spread of breast cancer. However, a laboratory-based study found it also degraded a different protein that triggers blood vessel growth.

Stopping unwanted blood vessel growth is a key challenge in the battle against cancer, according to Dr Sreenivasan Ponnambalam, reader in human disease biology in the University of Leeds' Faculty of Biological Sciences.

'Smoke-free' laws lead to fewer hospitalizations and deaths

Laws that end smoking at work and other public places result in significantly fewer hospitalizations for heart attacks, strokes, asthma and other respiratory conditions, a new UCSF analysis has found.

The research provides evidence that smoke-free laws that cover workplaces, restaurants and bars have the biggest impacts on hospitalizations, reduce health care costs and also raise quality of life, the researchers said.

Living abroad can bring success -- if you do it right

"Travel broadens the mind" goes the old adage, and potential employers often agree, valuing the open-mindedness and creativity fostered by such worldliness. But according to new Tel Aviv University research, not all international experiences are created equal.

Stem cell therapy using patient's own cells after heart attack does not enhance cardiac recovery

MINNEAPOLIS, MN – November 6, 2012 – Administering autologous stem cells obtained from bone marrow either 3 or 7 days following a heart attack did not improve heart function six months later, reports a new clinical trial supported by the National Institutes of Health. The results of this trial, called TIME (Transplantation In Myocardial Infarction Evaluation), were presented by Jay Traverse, MD of the Minneapolis Heart Institute Foundation Tuesday, Nov. 6, at the 2012 Scientific Sessions of the American Heart Association in Los Angeles.

Personalizing medicine: New American Chemical Society Prized Science video

WASHINGTON, Nov. 6, 2012 — Personalized medicine — the promise of customizing treatments that will work best for each individual patient — could get a boost from advances in understanding how the proteins that help determine health and disease take the three-dimensional shapes needed to work in the body. That's the message of the latest episode of the 2012 edition of a popular video series from the American Chemical Society (ACS), the world's largest scientific society.

New drug significantly lowers bad cholesterol

BOSTON, MA—For many people with high cholesterol, statins serve as the first line of treatment. However, some patients are unable to effectively reduce their low-density lipoprotein cholesterol (LDL cholesterol) or "bad cholesterol" levels with statins, the most commonly used medication to treat high cholesterol, due to their bodies' inability to tolerate or sufficiently respond to the medicine.

Team finds a new way to inhibit blood clotting and inflammation

CHAMPAIGN, lll. — Scientists have identified a group of small molecules that interfere with the activity of a compound that initiates multiple steps in blood clotting, including those that lead to the obstruction of veins or arteries, a condition called thrombosis. Blocking the activity of this compound, polyphosphate, could treat thrombosis with fewer bleeding side effects than the drugs that are currently on the market.

Their findings appear in the journal Blood.

How bacteria talk to each other and our cells

Bacteria can talk to each other via molecules they themselves produce. The phenomenon is called quorum sensing, and is important when an infection propagates. Now, researchers at Linköping University in Sweden are showing how bacteria control processes in human cells the same way.

The results are being published in the journal PLOS Pathogens with Elena Vikström, researcher in Medical Microbiology, as the main author.

Combating a crisis: Global burden of preterm birth can be reduced if critical actions are taken

New surveys of researchers and funders reveal a lack of consensus regarding researching and developing interventions to prevent prematurity and stillbirth, according to an article published in the American Journal of Obstetrics and Gynecology ahead of World Prematurity Day on November 17.

New bacteria to fight against intestinal inflammation

This protection is provided by a human protein, Elafin, which is artificially introduced into dairy produce bacteria (Lactococcus lactis and Lactobacillus casei). In time, this discovery could be useful for individuals suffering from chronic inflammatory diseases such as Crohn's disease or ulcerative colitis.The results of this research were published in the Science Translational Medicine review on 31 October 2012.